MedTrace Logo

Motivational Interviewing and Vaccine Hesitancy in Children

NCT03934008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4191

Last updated 2020-09-09

No results posted yet for this study

Summary

This study will assess the effectiveness of a motivational interviewing-based tool in addressing vaccine hesitancy expressed by parents or caregivers of children.

Conditions

  • Vaccine Hesitancy

Interventions

OTHER

MOtivational interviewing Tool to Improve Vaccine AdherencE (MOTIVE)

The MOTIVE tool incorporates the principles of motivational interviewing (MI) and provides a flowchart approach in which parental health beliefs have a corresponding MI-based strategy to further explore and/or address the hesitancy. The tool was developed from interviews with pediatricians and pediatric pharmacists, a review of the literature focusing on vaccine health beliefs, and the Parent Attitudes about Childhood Vaccines (PACV) Survey Tool. The tool was reviewed by multiple providers and feedback was provided on its usability in clinical practice when interacting with vaccine-hesitant parents and/or caregivers. The tool was then modified based on this feedback. Pediatric providers will complete four educational sessions on vaccine hesitancy, MI, and the use of the MOTIVE tool in clinical practice prior implementation.

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Rocking Horse Community Health Center

    collaborator UNKNOWN

  • Cedarville University

    lead OTHER

Principal Investigators

  • Justin W Cole, PharmD · Cedarville University School of Pharmacy

Eligibility

Min Age
0 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-03-09
Completion
2020-03-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934008 on ClinicalTrials.gov